Fresenius Medical Care AG (FMCQF) Notes Payables (2009 - 2026)

Fresenius Medical Care AG has reported Notes Payables for 18 years, with the latest figure at $540.1 million in Q2 2026.

• On a quarterly basis, Notes Payables fell 30.36% year-over-year to $540.1 million in Q2 2026; TTM through Jun 2026 was $540.1 million, a 30.36% decrease from a year earlier, with the FY2025 full-year figure at $858.6 million, down 11.15% from the prior year.
• Notes Payables was $540.1 million for Q2 2026 at Fresenius Medical Care AG, down from $902.5 million in the prior quarter.
• The five-year high for Notes Payables was $966.3 million in Q4 2024, with the low at $765228.3 in Q1 2023.
• Average Notes Payables over 5 years is $780.5 million, with a median of $832.3 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Notes Payables slumped 99.91% in 2023, then surged 102850.41% in 2024.
• Over 5 years, Notes Payables stood at $829.7 million in 2022, then slipped by 1.18% to $819.9 million in 2023, then grew by 17.85% to $966.3 million in 2024, then decreased by 11.15% to $858.6 million in 2025, then plunged by 37.1% to $540.1 million in 2026.
• The last three Notes Payables figures came in at $540.1 million (Q2 2026), $902.5 million (Q1 2026), and $858.6 million (Q4 2025), per Business Quant data.